NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nuroflux

Nuroflux

Private
SydneyHealthcare & Life Scienceshttps://nuroflux.com/

Last Round

Accelerator

May 11, 2022

Total Funding Raised

$129,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nuroflux is a medical device company developing a wearable to non-invasively monitor brain activity and brain blood flow for stroke patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Healthcare Analytics, Health IoT, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

continuous brain monitoringstroke monitoringwearable medical deviceneuromonitoringbrain blood flow monitoringmedtechelectroencephalographyEEGnon-invasive monitoringmedical AIclinical decision supporthealth IoTIoMTelectrocardiographyECG

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuroflux Comps

Public and private peers based on sector, stage, and business model.

Nuroflux comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nuroflux Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 11, 2022
GrantDec 14, 2021

Key People

Founding team and executive leadership

David Almeida Cardoso

Co-Founder and Chief Business Officer

Founding Team

Sam van Bohemen

Co-Founder, CEO & CTO

Founding Team

Nuroflux Investors

Notable investors and investment history

Nuroflux investors
InvestorRounds
Cerebral Palsy AllianceAccelerator
NSW GovernmentGrant
RemarkableAccelerator
UNSW FoundersAccelerator
The George Institute for Global HealthAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 146% MoM, from 401 to 988.

  • May 11, 2022

    $57K raised from Cerebral Palsy Alliance and Remarkable.

Nuroflux Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nuroflux Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nuroflux's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range4
Year Founded2020
Last FundingMay 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.